About Rhea Meditec Inc.

Rhea Meditec Inc commit to the application development of blood industry. Provide products and services including: Regenerated medicine and Cell therapy. We upholding three principles of “quality,” “safety,” and “economy”. Producing high-quality products,with safety as the standard. Vitalizing the economy of the blood technology industry. Continuously innovate and creating a triple-win glory for healthcare professionals, patients, and the industry.

HISTORY

Established in the 1980’s, SGC is now dedicated in Hema-technology through Transfusion Safety& Regenerative Medicine.

Began Leukocyte Reduction Filter Set Development.

Safetran BioMedical Inc. a spin-off company from SGC(established 1980). Pilot plant (Taipei, Taiwan) established

ISO 13485 granted.

Phoenix ® Autologous Bio-active Molecules Enrich System commercially launched with CE approval as 2nd class medical device. Phoenix ® Autologous Bio-active Molecules Enrich System applied in Orthopedics treatments.

  • ISO/CE certification granted by BSI.
  • Novelty membrane project acheived successfully.
  • Phoenix ® Autologous Bio-active Molecules Enrich System applied in Sports Medicine treatments by Olympic team doctors of Taiwan.
  • Rhea® Launched into Ophthalmology medicine.
  • Novelty Membrane patent pending.
  • Mass production project kick-off.
  • The pilot plant of Sangtech got GMP.

  • The commercial plant of Green Membrane completed.
  • Green Membrane of Sangtech was shortlisted for R&D 100 Awards.
  • Rhea Meditec Inc was established from Safetran BioMedical Inc.- Regenerative Medicine Department to specialize in promoting the regenerative medicine market.

    HISTORY

    Established in the 1980’s, SGC is now dedicated in Hema-technology through Transfusion Safety& Regenerative Medicine.

    Began Leukocyte Reduction Filter Set Development.

    Safetran BioMedical Inc. a spin-off company from SGC(established 1980). Pilot plant (Taipei, Taiwan) established

    ISO 13485 granted.

    Phoenix ® Autologous Bio-active Molecules Enrich System commercially launched with CE approval as 2nd class medical device. Phoenix ® Autologous Bio-active Molecules Enrich System applied in Orthopedics treatments.

  • ISO/CE certification granted by BSI.
  • Novelty membrane project acheived successfully.
  • Phoenix 開始菁英運動員照護計畫
  • Rhea® Launched into Ophthalmology medicine.
  • Novelty Membrane patent pending.
  • Mass production project kick-off.
  • The pilot plant of Sangtech got GMP.

  • The commercial plant of Green Membrane completed.
  • Green Membrane of Sangtech was shortlisted for R&D 100 Awards.
  • Rhea Meditec Inc was established from Safetran BioMedical Inc.- Regenerative Medicine Department to specialize in promoting the regenerative medicine market.

    Scroll to Top